The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Cellular Therapies - T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah - Novartis Pharmaceuticals Australia Pty Ltd - Suspension - Bag (475975)
ARTG Name
Cellular Therapies - T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah - Novartis Pharmaceuticals Australia Pty Ltd - Suspension - Bag
Product name
T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah
ARTG Date
Registration Type
Biological
Therapeutic good type
Biological
Ingredients
tisagenlecleucel
Licence category
INC
Licence status
A
Licence class
Class 4
Summary
Product Information
Consumer Medicine Information